Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 101–200 of 1,001
Engineered materials for in vivo delivery of genome-editing machinery
Tong, S., Moyo, B., Lee, C. M., Leong, K., & Bao, G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0145-9 · Cited by 205
Genome Editing in Rice: Recent Advances, Challenges, and Future Implications
Mishra, R., Joshi, R. K., & Zhao, K. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01361 · Cited by 200
Development of an Agrobacterium‐delivered CRISPR/Cas9 system for wheat genome editing
Zhang, Z., Hua, L., Gupta, A., Tricoli, D., Edwards, K. J., Yang, B., & Li, W. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13088 · Cited by 201
In vivo somatic cell base editing and prime editing
Newby, G. A., & Liu, D. R. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.002 · Cited by 199
Web-based design and analysis tools for CRISPR base editing
Hwang, G.-H., Park, J., Lim, K., Kim, S., Yu, J., Yu, E., Kim, S.-T., Eils, R., Kim, J.-S., & Bae, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2585-4 · Cited by 198
Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo
Yarrington, R. M., Verma, S., Schwartz, S., Trautman, J. K., & Carroll, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810062115 · Cited by 194
Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG
Zhong, Z., Sretenovic, S., Ren, Q., Yang, L., Bao, Y., Qi, C., Yuan, M., He, Y., Liu, S., Liu, X., et al. (2019) · Molecular Plant · doi:10.1016/j.molp.2019.03.011 · Cited by 196
Plant Prime Editors Enable Precise Gene Editing in Rice Cells
Tang, X., Sretenovic, S., Ren, Q., Jia, X., Li, M., Fan, T., Yin, D., Xiang, S., Guo, Y., Liu, L., et al. (2020) · Molecular Plant · doi:10.1016/j.molp.2020.03.010 · Cited by 196
Base editors for simultaneous introduction of C-to-T and A-to-G mutations
Sakata, R. C., Ishiguro, S., Mori, H., Tanaka, M., Tatsuno, K., Ueda, H., Yamamoto, S., Seki, M., Masuyama, N., Nishida, K., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0509-0 · Cited by 196
Self-citationGenome-wide target specificity of CRISPR RNA-guided adenine base editors
Kim, D., Kim, D.-E., Lee, G., Cho, S.-I., & Kim, J.-S. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0050-1 · Cited by 191
Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins
Chen, L., Park, J. E., Paa, P., Rajakumar, P. D., Prekop, H.-T., Chew, Y. T., Manivannan, S. N., & Chew, W. L. (2021) · Nature Communications · doi:10.1038/s41467-021-21559-9 · Cited by 195
Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus Resistance
Zaidi, S. S.-E.-A., Tashkandi, M., Mansoor, S., & Mahfouz, M. M. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01673 · Cited by 189
Engineering of high-precision base editors for site-specific single nucleotide replacement
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2019) · Nature Communications · doi:10.1038/s41467-018-08034-8 · Cited by 186
Genome editing in plants by engineered CRISPR–Cas9 recognizing NG PAM
Endo, M., Mikami, M., Endo, A., Kaya, H., Itoh, T., Nishimasu, H., Nureki, O., & Toki, S. (2018) · Nature Plants · doi:10.1038/s41477-018-0321-8 · Cited by 185
Yeh, W.-H., Shubina-Oleinik, O., Levy, J. M., Pan, B., Newby, G. A., Wornow, M., Burt, R., Chen, J. C., Holt, J. R., & Liu, D. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9101 · Cited by 185
Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system
Zhang, Y., Qin, W., Lu, X., Xu, J., Huang, H., Bai, H., Li, S., & Lin, S. (2017) · Nature Communications · doi:10.1038/s41467-017-00175-6 · Cited by 184
CRISPR-SKIP: programmable gene splicing with single base editors
Gapinske, M., Luu, A., Winter, J., Woods, W. S., Kostan, K. A., Shiva, N., Song, J. S., & Perez-Pinera, P. (2018) · Genome Biology · doi:10.1186/s13059-018-1482-5 · Cited by 184
CRISPR Correction of Duchenne Muscular Dystrophy
Min, Y.-L., Bassel-Duby, R., & Olson, E. N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-010451 · Cited by 183
Development of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 181
Bastet, A., Zafirov, D., Giovinazzo, N., Guyon‐Debast, A., Nogué, F., Robaglia, C., & Gallois, J. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13096 · Cited by 179
MACBETH: Multiplex automated Corynebacterium glutamicum base editing method
Wang, Y., Liu, Y., Liu, J., Guo, Y., Fan, L., Ni, X., Zheng, X., Wang, M., Zheng, P., Sun, J., et al. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.02.016 · Cited by 179
CRISPR–Cas: a tool for cancer research and therapeutics
Yin, H., Xue, W., & Anderson, D. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0166-8 · Cited by 178
Li, C., Brant, E., Budak, H., & Zhang, B. (2021) · Journal of Zhejiang University-SCIENCE B · doi:10.1631/jzus.b2100009 · Cited by 177
CRISPR/Cas system for yeast genome engineering: advances and applications
Stovicek, V., Holkenbrink, C., & Borodina, I. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox030 · Cited by 176
Precision genome editing using cytosine and adenine base editors in mammalian cells
Huang, T. P., Newby, G. A., & Liu, D. R. (2021) · Nature Protocols · doi:10.1038/s41596-020-00450-9 · Cited by 175
The road ahead in genetics and genomics
McGuire, A. L., Gabriel, S., Tishkoff, S. A., Wonkam, A., Chakravarti, A., Furlong, E. E. M., Treutlein, B., Meissner, A., Chang, H. Y., López-Bigas, N., et al. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0272-6 · Cited by 188
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Bez Batti Angulski, A., Hosny, N., Cohen, H., Martin, A. A., Hahn, D., Bauer, J., & Metzger, J. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1183101 · Cited by 173
Mans, R., Daran, J.-M. G., & Pronk, J. T. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.10.011 · Cited by 173
Genome editing of crops: A renewed opportunity for food security
Georges, F., & Ray, H. (2017) · GM Crops & Food · doi:10.1080/21645698.2016.1270489 · Cited by 173
Designing and executing prime editing experiments in mammalian cells
Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J., & Liu, D. R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00724-4 · Cited by 172
Evaluating and enhancing target specificity of gene-editing nucleases and deaminases
Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171
Efficient targeted insertion of large DNA fragments without DNA donors
Wang, J., He, Z., Wang, G., Zhang, R., Duan, J., Gao, P., Lei, X., Qiu, H., Zhang, C., Zhang, Y., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01399-1 · Cited by 168
Towards systems metabolic engineering in Pichia pastoris
Schwarzhans, J.-P., Luttermann, T., Geier, M., Kalinowski, J., & Friehs, K. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.07.009 · Cited by 168
Raschmanová, H., Weninger, A., Glieder, A., Kovar, K., & Vogl, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.006 · Cited by 164
Rationally designed APOBEC3B cytosine base editors with improved specificity
Jin, S., Fei, H., Zhu, Z., Luo, Y., Liu, J., Gao, S., Zhang, F., Chen, Y.-H., Wang, Y., & Gao, C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.005 · Cited by 159
Wang, X.-W., Hu, L.-F., Hao, J., Liao, L.-Q., Chiu, Y.-T., Shi, M., & Wang, Y. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0292-7 · Cited by 158
Unbiased investigation of specificities of prime editing systems in human cells
Kim, D. Y., Moon, S. B., Ko, J.-H., Kim, Y.-S., & Kim, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa764 · Cited by 157
CRISPR-Cas9/Cas12a biotechnology and application in bacteria
Yao, R., Liu, D., Jia, X., Zheng, Y., Liu, W. Y., & Xiao, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.09.004 · Cited by 173
Current Status and Challenges of DNA Base Editing Tools
Jeong, Y. K., Song, B., & Bae, S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.021 · Cited by 164
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
Yang, Y., Xu, J., Ge, S., & Lai, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649896 · Cited by 193
Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
Yuan, J., Ma, Y., Huang, T., Chen, Y., Peng, Y., Li, B., Li, J., Zhang, Y., Song, B., Sun, X., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.002 · Cited by 151
CRISPR/Cas9 in insects: Applications, best practices and biosafety concerns
Taning, C. N. T., Eynde, B. V., Yu, N., Ma, S., & Smagghe, G. J. (2017) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2017.01.007 · Cited by 170
A Processive Protein Chimera Introduces Mutations across Defined DNA Regions In Vivo
Moore, C., Papa, L. J., & Shoulders, M. D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04001 · Cited by 145
Immunity to CRISPR Cas9 and Cas12a therapeutics
Chew, W. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1408 · Cited by 147
Highly efficient RNA-guided base editing in rabbit
Liu, Z., Chen, M., Chen, S., Deng, J., Song, Y., Lai, L., & Li, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-05232-2 · Cited by 145
Wang, H., Wu, Y., Zhang, Y., Yang, J. M., Fan, W., Zhang, H., Zhao, S., Yuan, L., & Zhang, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194702 · Cited by 170
Improved plant cytosine base editors with high editing activity, purity, and specificity
Ren, Q., Sretenovic, S., Liu, G., Zhong, Z., Wang, J., Huang, L., Tang, X., Guo, Y., Liu, L., Wu, Y., et al. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13635 · Cited by 131
Pacher, M., & Puchta, H. (2017) · The Plant Journal · doi:10.1111/tpj.13469 · Cited by 145
Kim, H. K., Lee, S., Kim, Y., Park, J., Min, S., Choi, J. W., Huang, T. P., Yoon, S., Liu, D. R., & Kim, H. H. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0505-1 · Cited by 145
Deafness: from genetic architecture to gene therapy
Petit, C., Bonnet, C., & Safieddine, S. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00597-7 · Cited by 154
Synthetic Biology Toolbox and Chassis Development in Bacillus subtilis
Liu, Y., Liu, L., Li, J., Du, G., & Chen, J. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.10.005 · Cited by 154
Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor
Wang, L., Xue, W., Yan, L., Li, X., Wei, J., Chen, M., Wu, J., Yang, B., Yang, L., & Chen, J. (2017) · Cell Research · doi:10.1038/cr.2017.111 · Cited by 138
Zhang, X., Chen, L., Zhu, B., Wang, L., Chen, C., Hong, M., Huang, Y., Li, H., Han, H., Cai, B., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0518-8 · Cited by 144
Campbell, C. R., Poelstra, J. W., & Yoder, A. D. (2018) · Biological Journal of the Linnean Society · doi:10.1093/biolinnean/bly063 · Cited by 150
Adenine base editors catalyze cytosine conversions in human cells
Kim, H. S., Jeong, Y. K., Hur, J. K., Kim, J., & Bae, S. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0254-4 · Cited by 129
RNA‐based medicine: from molecular mechanisms to therapy
Sparmann, A., & Vogel, J. (2023) · The EMBO Journal · doi:10.15252/embj.2023114760 · Cited by 157
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 134
Kumlehn, J., Pietralla, J., Hensel, G., Pacher, M., & Puchta, H. (2018) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12734 · Cited by 154
Evolution of Alternative Adaptive Immune Systems in Vertebrates
Boehm, T. L. J., Hirano, M., Holland, S. J., Das, S., Schorpp, M., & Cooper, M. D. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053028 · Cited by 148
Editing the microbiome the CRISPR way
Ramachandran, G., & Bikard, D. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0103 · Cited by 138
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S. A., Kostyusheva, A. P., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 139
Sequence-specific prediction of the efficiencies of adenine and cytosine base editors
Song, M., Kim, H. K., Lee, S., Kim, Y., Seo, S.-Y., Park, J., Choi, J. W., Jang, H., Shin, J. H., Min, S., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0573-5 · Cited by 124
Mitochondrial base editor induces substantial nuclear off-target mutations
Lei, Z., Meng, H., Liu, L., Zhao, H., Rao, X., Yan, Y., Wu, H., Liu, M., He, A., & Yi, C. (2022) · Nature · doi:10.1038/s41586-022-04836-5 · Cited by 134
Expanding the CRISPR Toolbox in Zebrafish for Studying Development and Disease
Liu, K., Petree, C., Requena, T., Varshney, P., & Varshney, G. K. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00013 · Cited by 155
CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
Horodecka, K., & Düchler, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116072 · Cited by 121
The Solanum tuberosum GBSSI gene: a target for assessing gene and base editing in tetraploid potato
Veillet, F., Chauvin, L., Kermarrec, M.-P., Sevestre, F., Merrer, M., Terret, Z., Szydlowski, N., Devaux, P., Gallois, J.-L., & Chauvin, J.-E. (2019) · Plant Cell Reports · doi:10.1007/s00299-019-02426-w · Cited by 124
BE-PLUS: a new base editing tool with broadened editing window and enhanced fidelity
Jiang, W., Feng, S., Huang, S., Yu, W., Li, G., Yang, G., Liu, Y., Zhang, Y., Zhang, L., Hou, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0052-4 · Cited by 133
Genome editing for plant research and crop improvement
Zhan, X., Lu, Y., Zhu, J., & Botella, J. R. (2020) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13063 · Cited by 126
Single-Nucleotide-Resolution Computing and Memory in Living Cells
Farzadfard, F., Gharaei, N., Higashikuni, Y., Jung, G., Cao, J., & Lu, T. K. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.011 · Cited by 122
Efficient base editing for multiple genes and loci in pigs using base editors
Xie, J., Ge, W., Li, N., Liu, Q., Chen, F., Yang, X., Huang, X., Ouyang, Z., Zhang, Q., Zhao, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10421-8 · Cited by 122
Kluesner, M. G., Lahr, W. S., Lonetree, C.-L., Smeester, B. A., Qiu, X., Slipek, N. J., Claudio Vázquez, P. N., Pitzen, S. P., Pomeroy, E. J., Vignes, M. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22009-2 · Cited by 121
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
Huang, C., Lee, K.-C., & Doudna, J. A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.006 · Cited by 127
Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation
Mahas, A., Neal Stewart, C., & Mahfouz, M. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.008 · Cited by 110
Multiplex genome editing of microorganisms using CRISPR-Cas
Adiego-Pérez, B., Randazzo, P., Daran, J.-M. G., Verwaal, R., Roubos, J. A., Daran-Lapujade, P. A. S., & John van der, O. O. S. T. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz086 · Cited by 122
Sürün, D., Schneider, A., Mircetic, J., Neumann, K., Lansing, F., Paszkowski-Rogacz, M., Hänchen, V., Lee-Kirsch, M. A., & Buchholz, F. (2020) · Genes · doi:10.3390/genes11050511 · Cited by 120
CRISPR/Cas9-mediated noncoding RNA editing in human cancers
Yang, J., Meng, X., Pan, J., Jiang, N., Zhou, C., Wu, Z., & Gong, Z. (2017) · RNA Biology · doi:10.1080/15476286.2017.1391443 · Cited by 141
Genome editing by natural and engineered CRISPR-associated nucleases
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N., & John van der, O. O. S. T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0080-x · Cited by 124
Bisht, D. S., Bhatia, V., & Bhattacharya, R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.008 · Cited by 130
Base editing in plants: Current status and challenges
Bharat, S. S., Li, S., Li, J., Yan, L., & Xia, L. (2019) · The Crop Journal · doi:10.1016/j.cj.2019.10.002 · Cited by 133
PE-Designer and PE-Analyzer: web-based design and analysis tools for CRISPR prime editing
Hwang, G.-H., Jeong, Y. K., Habib, O., Hong, S.-A., Lim, K., Kim, J.-S., & Bae, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab319 · Cited by 117
Editing the Genome Without Double-Stranded DNA Breaks
Komor, A. C., Badran, A. H., & Liu, D. R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00710 · Cited by 113
Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response
Wang, X., Ding, C., Yu, W., Wang, Y., He, S., Yang, B., Xiong, Y.-C., Wei, J., Li, J., Liang, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107723 · Cited by 109
Polymerase-guided base editing enables in vivo mutagenesis and rapid protein engineering
Cravens, A., Jamil, O. K., Kong, D., Sockolosky, J. T., & Smolke, C. D. (2021) · Nature Communications · doi:10.1038/s41467-021-21876-z · Cited by 123
The Role of Noncoding Variants in Heritable Disease
French, J. D., & Edwards, S. L. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.07.004 · Cited by 146
Efficient precise in vivo base editing in adult dystrophic mice
Xu, L., Zhang, C., Li, H., Wang, P., Gao, Y., Mokadam, N. A., Ma, J., Arnold, W. D., & Han, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23996-y · Cited by 112
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Broeders, M., Herrero-Hernandez, P., Ernst, M. P. T., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2019) · iScience · doi:10.1016/j.isci.2019.100789 · Cited by 127
Gene therapy: a double-edged sword with great powers
Tang, R., & Xu, Z. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03834-3 · Cited by 134
Editing the genome of hiPSC with CRISPR/Cas9: disease models
Bassett, A. R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9684-9 · Cited by 109
Potato Virus X Vector-Mediated DNA-Free Genome Editing in Plants
Ariga, H., Toki, S., & Ishibashi, K. (2020) · Plant and Cell Physiology · doi:10.1093/pcp/pcaa123 · Cited by 119
Pramanik, D., Shelake, R. M., Kim, M. J., & Kim, J.-Y. (2021) · Molecular Plant · doi:10.1016/j.molp.2020.11.002 · Cited by 108
Engineered prime editors with PAM flexibility
Kweon, J., Yoon, J.-K., Jang, A.-H., Shin, H. R., See, J.-E., Jang, G., Kim, J.-I., & Kim, Y. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.022 · Cited by 109
Precision genome engineering through adenine and cytosine base editing
Kim, J. (2018) · Nature Plants · doi:10.1038/s41477-018-0115-z · Cited by 116
Genome Editing Tools in Plants
Mohanta, T., Bashir, T., Hashem, A., Abd_Allah, E., & Bae, H. (2017) · Genes · doi:10.3390/genes8120399 · Cited by 106
Mukai, H., Ogawa, K., Kato, N., & Kawakami, S. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100450 · Cited by 117
Tools for experimental and computational analyses of off-target editing by programmable nucleases
Bao, X. R., Pan, Y., Lee, C. M., Davis, T. H., & Bao, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00431-y · Cited by 106
Continuous directed evolution of proteins with improved soluble expression
Wang, T., Badran, A. H., Huang, T. P., & Liu, D. R. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0121-5 · Cited by 105
Wang, Y., Cheng, H., Liu, Y., Liu, Y., Xiao, W., Zhang, K., Ni, X., Gao, N., Fan, L., Zhang, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21003-y · Cited by 114
Improving CRISPR Genome Editing by Engineering Guide RNAs
Moon, S. B., Kim, D. Y., Ko, J., Kim, J., & Kim, Y.-S. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.01.009 · Cited by 111
Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants
Mushtaq, M., Sakina, A., Wani, S. H., Shikari, A. B., Tripathi, P., Zaid, A., Galla, A., Abdelrahman, M., Sharma, M., Singh, A. K., et al. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00550 · Cited by 104
CRISPR technologies for stem cell engineering and regenerative medicine
Hsu, M.-N., Chang, Y.-H., Truong, V. A., Lai, P.-L., Nguyen, T. K. N., & Hu, Y.-C. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107447 · Cited by 104
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.